SCARDINO, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 120
AS - Asia 53
EU - Europa 44
SA - Sud America 8
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
Totale 237
Nazione #
US - Stati Uniti d'America 114
SG - Singapore 24
CN - Cina 11
IT - Italia 11
RU - Federazione Russa 11
SE - Svezia 9
VN - Vietnam 8
BR - Brasile 6
GB - Regno Unito 4
HK - Hong Kong 4
CA - Canada 3
CI - Costa d'Avorio 3
DE - Germania 3
FR - Francia 3
LT - Lituania 2
MX - Messico 2
BO - Bolivia 1
IL - Israele 1
IN - India 1
IR - Iran 1
KE - Kenya 1
MA - Marocco 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 231
Città #
Ashburn 28
San Jose 16
Singapore 15
Chandler 6
Nyköping 6
Beijing 5
Council Bluffs 4
Hong Kong 4
New York 4
Abidjan 3
Ho Chi Minh City 3
Dallas 2
Fairfield 2
Hanoi 2
Los Angeles 2
Miano 2
Santa Clara 2
Seattle 2
Albany 1
Ardabil 1
Atlanta 1
Avon 1
Boardman 1
Boisbriand 1
Boston 1
Brooklyn 1
Buffalo 1
Cambridge 1
Caposele 1
Changsha 1
Chennai 1
Chicago 1
Columbus 1
Criciúma 1
Des Moines 1
Faisalabad 1
Falkenstein 1
Fayetteville 1
Garbagnate Milanese 1
Guarulhos 1
Harrisburg 1
Helena 1
Houston 1
Indianapolis 1
Itaquaquecetuba 1
Johannesburg 1
Kansas City 1
Lambersart 1
Lawrence 1
Loma Plata 1
Long Xuyen 1
Manchester 1
Manila 1
Marsabit 1
Mexico City 1
Miami 1
Montreal 1
Moscow 1
Nanjing 1
Nottingham 1
Nuremberg 1
Pawleys Island 1
Pittsfield 1
Puebla City 1
Purcellville 1
Renqiu 1
Ribeirão das Neves 1
Romano d'Ezzelino 1
Rome 1
Roxbury 1
Salerno 1
San Francisco 1
San Salvador 1
Sertãozinho 1
Sucre 1
Surgut 1
São Paulo 1
Tangier 1
Tashkent 1
Tel Aviv 1
Toronto 1
Warner Robins 1
Zionsville 1
Totale 173
Nome #
LIGHT INVOLVEMENT IN MULTIPLE MYELOMA-OSTEOLYTIC BONE DISEASE 125
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma 94
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real‐World Study 11
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort 7
Totale 237
Categoria #
all - tutte 870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 1 1 1 0 0 0 1 1 4
2022/202316 3 3 2 1 2 1 0 1 2 0 1 0
2023/20247 0 0 0 1 1 4 0 0 0 0 0 1
2024/202537 2 1 1 0 2 4 8 8 1 0 5 5
2025/2026102 17 6 7 13 12 7 6 3 13 10 3 5
2026/202760 8 15 15 22 0 0 0 0 0 0 0 0
Totale 237